title: A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings.
abstract: Molecular dynamics (MD) simulations followed by principal component analysis were performed to study the conformational change of MDM2 induced by p53 and two inhibitor (P4 and MI63a) bindings. The results show that the hydrophobic cleft of MDM2 is very flexible and adaptive to different structural binding partners. The cleft tends to become wider and more stable as MDM2 binds to the three binding partners, while unbound MDM2 shows a narrower and pretty flexible cleft, which agrees with recent experimental data and theoretical studies. It was also found that the binding of P4 and p53 stabilizes the motion of the loop L2 linking the helix α2 and β strand (β3), but the presence of MI63a makes the motion of L2 disordered. In addition, the binding free energies of the three partners to MDM2 were calculated using molecular mechanics generalized Born surface area to explain the binding modes of these three partners to MDM2. This study will be helpful not only for better understanding the functional, concerted motion of MDM2, but also for the rational design of potent anticancer drugs targeting the p53-MDM2 interaction.
authors.affiliation: School of Science, Shandong Jiaotong University, Jinan, 250014, China, chenjianzhong1970@163.com.
authors.forename: Jianzhong
authors.initials: J
authors.lastname: Chen
authors.forename: Jinan
authors.initials: J
authors.lastname: Wang
authors.forename: Weiliang
authors.initials: W
authors.lastname: Zhu
authors.forename: Guohui
authors.initials: G
authors.lastname: Li
mesh_terms: D000595:Amino Acid Sequence; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology; D001665:Binding Sites; D015195:Drug Design; D006801:Humans; D056004:Molecular Dynamics Simulation; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D025341:Principal Component Analysis; D011485:Protein Binding; D011487:Protein Conformation / Q000187:drug effects*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D013816:Thermodynamics; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D016159:Tumor Suppressor Protein p53; D051736:Proto-Oncogene Proteins c-mdm2